Shocking Moment at White House Obesity-Drug Event
During a press event on Thursday at the White House, Gordon Findlay, an executive from Novo Nordisk, collapsed as President Donald Trump announced price cuts on obesity drugs.
Mr. Findlay, an elderly pharmaceutical executive, had reportedly visited the White House specifically for this occasion. President Trump and other officials quickly assisted him.
“During the Most Favoured Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.” — White House Press Secretary Karoline Leavitt
Event Highlights
The event included top pharmaceutical executives and administration officials. Companies Eli Lilly and Novo Nordisk announced a deal to offer their GLP-1 weight loss drugs at significantly reduced prices.
About the Journalist
Kushal Deb is a mid-career journalist with seven years of experience and a strong academic background, passionate about research, storytelling, economics, and policy.
Summary: At a White House event announcing obesity drug price cuts, Novo Nordisk executive Gordon Findlay unexpectedly collapsed but was quickly aided and recovered, while major pharmaceutical firms committed to lowering drug prices.